Pre-exposure prophylaxis (PrEP) is the advent of antiretroviral treatment use for people at increased risk of acquiring HIV-1 ...

While PrEP can prevent HIV, it does not protect against other sexually transmitted infections or pregnancy. PrEP stand for pre-exposure prophylaxis. This means it prevents you from getting HIV by ...

Like most prescribed medications, all three brands PrEP brands feature side effects. Here's how to prepare for them.

An annual jab to protect against HIV “shows potential”, according to an early study. Millions of people around the world are ...

Utilizing syringe service programs to provide comprehensive PrEP care shows promise for encouraging more people who inject ...

Gilead Sciences announced a significant milestone: the U.S. FDA accepted their New Drug Applications (NDAs) for lenacapavir ...

Cabotegravir was found to prevent HIV acquisition as a monotherapy pre-exposure prophylaxis (PrEP) and to treat HIV as a ...

CNW/ - ViiV Healthcare, the global specialist HIV company majority owned by GlaxoSmithKline plc (GSK), with Pfizer Inc. and ...

Both drugs are concentrated in genital secretions as compared to plasma which is desirable for a pre-exposure prophylaxis (PrEP) agent. The signature mutations for TDF resistance are K65R and K70E ...

Gilead (GILD) stock in focus as its HIV anti-viral lenacapavir shows promise in HIV prevention with once-yearly PrEP ...

A groundbreaking annual injection designed to protect against HIV has successfully passed its first safety trial, bringing new hope for long-term prevention.The drug, Lenacapavir, prevents the virus ...

Sciences presented the first data from its ongoing Phase 1 study investigating two novel, once-yearly formulations of ...